News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
OH ANDREW M.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| OH ANDREW M. (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 4,000 shares
@ $0
Granted 6,000 options to buy
@ $3.7, valued at
$22.2k
|
|
| 09/19/2022 |
4
| OH ANDREW M. (Director) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Granted 8,000 shares
@ $0
Granted 12,000 options to buy
@ $7.349, valued at
$88.2k
|
|
| 09/19/2022 |
3
| OH ANDREW M. (Director) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
| 05/19/2020 |
4
| OH ANDREW M. (CFO) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Exercised 5,000 options to buy
@ $4.74, valued at
$23.7k
|
|
| 02/03/2020 |
4
| OH ANDREW M. (CFO) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 165,000 options to buy
@ $7.8, valued at
$1.3M
|
|
| 02/04/2019 |
4
| OH ANDREW M. (CFO) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Granted 115,000 options to buy
@ $13.69, valued at
$1.6M
|
|
| 07/17/2018 |
3
| OH ANDREW M. (CFO) has filed a Form 3 on Rubius Therapeutics, Inc. |
|
|